Literature DB >> 19691484

Comparison between hirudin and citrate in monitoring the inhibitory effects of P2Y12 receptor antagonists with different platelet function tests.

C A C M Pittens, H J Bouman, J W van Werkum, J M ten Berg, C M Hackeng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19691484     DOI： 10.1111/j.1538-7836.2009.03585.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

1.  A new reversible and potent P2Y12 receptor antagonist (ACT-246475): tolerability, pharmacokinetics, and pharmacodynamics in a first-in-man trial.

Authors:  Daniela Baldoni; Shirin Bruderer; Andreas Krause; Marcello Gutierrez; Pierre Gueret; Béatrice Astruc; Jasper Dingemanse
Journal:  Clin Drug Investig       Date:  2014-11       Impact factor: 2.859

2.  Shear-induced platelet aggregation: 3D-grayscale microfluidics for repeatable and localized occlusive thrombosis.

Authors:  Michael T Griffin; Dongjune Kim; David N Ku
Journal:  Biomicrofluidics       Date:  2019-10-01       Impact factor: 2.800

3.  Assessment of Multiplate platelet aggregometry using citrate, heparin or hirudin in Rhesus macaques.

Authors:  Greg Dugan; Lisa O'Donnell; David B Hanbury; J Mark Cline; David L Caudell
Journal:  Platelets       Date:  2014-12-30       Impact factor: 3.862

4.  Platelet aggregation and coagulation factors in orthopedic surgery.

Authors:  Brandon S Oberweis; Germaine Cuff; Andrew Rosenberg; Luis Pardo; Michael A Nardi; Yu Guo; Ezra Dweck; Mitchell Marshall; David Steiger; Steven Stuchin; Jeffrey S Berger
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

5.  Platelet function tests: why they fail to guide personalized antithrombotic medication.

Authors:  Diana A Gorog; Young-Hoon Jeong
Journal:  J Am Heart Assoc       Date:  2015-05-26       Impact factor: 5.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.